# POSACONAZOLE
> **ANDA211500** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2023-12-26
## Drug
- **FDA Application Number:** ANDA211500
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POSACONAZOLE
- **Generic name:** POSACONAZOLE
- **Active ingredients:** POSACONAZOLE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MYLAN LABS LTD
- **Manufacturer:** Mylan Institutional LLC
- **First approval:** 2023-12-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211500)
---
*AI Analytics · CC0 1.0*